Exenatide is understood to be renally eliminated and therefore not considered to be influenced by hepatic impairment [8]
We monitor weight, BMI, body measurements, appetite changes, energy levels, and overall well-being
GLP-1 enhances glucose absorption and utilisation in muscle and adipose tissue by facilitating the translocation of GLUT4 to the cell membrane (Chang et al
Reported benefits (per available research): Studied for its ability to raise GH and IGF-1 toward youthful levels and blunt age-related loss of fat-free mass, based on a 2-year randomized, placebo-controlled trial in 65 healthy older adults (Nass et al., 2008, Annals of Internal Medicine, PMID 18981485)
Therapeutic Research Protocol Dose: 0.3 0.5 mg (= 610 clicks) Duration: 12 weeks Frequency: 2 3 daily, spaced 4 6 hours apart Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-amplitude GH and IGF-1 elevation in regenerative and metabolic models